$0.352
-0.196 (-55.73%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RVPH por análisis de gráficos similares
Alphio's RVPH stock price prediction model matches the current Reviva Pharmaceuticals Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.35 (+0.43%). The 1-week path is $0.36 (+2.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Reviva Pharmaceuticals Holdings Inc?
RVPH is not a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock is in a severe downtrend, the company is facing financing and listing risk, analysts have turned more cautious, and the current share price is far below key technical levels. Even though there are a few long-term pipeline positives, the balance of evidence says to avoid buying this stock now.
RVPH cerró en $0.35 el Wednesday, tras bajar -55.73%
Reviva Pharmaceuticals Holdings Inc (RVPH) last closed at $0.3521, losing -55.73%. These facts feed the 1-day and 1-week RVPH price prediction above.
Factores de la previsión
Los factores de la previsión de Reviva Pharmaceuticals Holdings Inc (RVPH) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RVPH, ordenadas por similitud.
Análisis de estacionalidad de RVPH
Historically the probability of a positive August return for RVPH is 0.00%. January offers the highest probability of a positive month at 24.59%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RVPH
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.43 | $0.47 | $0.54 | +33.03% |
| Sep 2026 | $0.43 | $0.44 | $0.45 | +24.05% |
| Oct 2026 | $0.34 | $0.40 | $0.47 | +14.85% |
| Nov 2026 | $0.31 | $0.36 | $0.36 | +2.25% |
| Dec 2026 | $0.36 | $0.38 | $0.41 | +6.54% |
En 2026, se proyecta que Reviva Pharmaceuticals Holdings Inc (RVPH) oscile entre $0.31 y $0.54.
Previsión mensual de Reviva Pharmaceuticals Holdings Inc para 2026
En Aug de 2026, se proyecta que Reviva Pharmaceuticals Holdings Inc promedie $0.47, con un mínimo de $0.43 y un máximo de $0.54.
En Sep de 2026, se proyecta que Reviva Pharmaceuticals Holdings Inc promedie $0.44, con un mínimo de $0.43 y un máximo de $0.45.
En Oct de 2026, se proyecta que Reviva Pharmaceuticals Holdings Inc promedie $0.40, con un mínimo de $0.34 y un máximo de $0.47.
En Nov de 2026, se proyecta que Reviva Pharmaceuticals Holdings Inc promedie $0.36, con un mínimo de $0.31 y un máximo de $0.36.
En Dec de 2026, se proyecta que Reviva Pharmaceuticals Holdings Inc promedie $0.38, con un mínimo de $0.36 y un máximo de $0.41.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.